Storyline
FDA approves leucovorin for rare cerebral folate deficiency but not for autism
The FDA has approved Wellcovorin (leucovorin calcium) tablets for treating cerebral folate deficiency in patients with a confirmed folate receptor 1 gene variant (CFD-FOLR1).
Evidence locked
Today's free sample is only available for the edition's flagship storyline.
Evidence preview
- FDA press announcement on leucovorin approvalfda.gov
- FDA approves leucovorin – but not for autismpharmaphorum
- FDA declines to endorse leucovorin for autism, walking back earlier statements suggesting benefitbiotech
- Reflecting the FDA's commitment to accelerating cures and expanding treatment options for patients with serious and u...US_FDA